Shiraz E-Medical Journal

Published by: Neoscriber Demo Publisher

Prevalence of Dermatologic Features in Patients With Ischemic Heart Disease

Morteza Abdar-Esfahani 1 , * and Meisam Abdar-Esfahani 2
Authors Information
1 Department of Cardiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran
2 Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran
Article information
  • Shiraz E-Medical Journal: January 01, 2015, 16 (1); e26243
  • Published Online: January 27, 2015
  • Article Type: Research Article
  • Received: December 20, 2014
  • Accepted: December 22, 2014
  • DOI: 10.17795/semj26243

To Cite: Abdar-Esfahani M, Abdar-Esfahani M. Prevalence of Dermatologic Features in Patients With Ischemic Heart Disease, Shiraz E-Med J. 2015 ; 16(1):e26243. doi: 10.17795/semj26243.

Copyright © 2015, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Tehrani DM, Seto AH. Third universal definition of myocardial infarction: update, caveats, differential diagnoses. Cleve Clin J Med. 2013; 80(12): 777-86[DOI][PubMed]
  • 2. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation. 2012; 126(16): 2020-35[DOI][PubMed]
  • 3. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2197-223[DOI][PubMed]
  • 4. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997; 349(9061): 1269-76[DOI][PubMed]
  • 5. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007; 370(9603): 1929-38[DOI][PubMed]
  • 6. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979; 2(2): 131-41[PubMed]
  • 7. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979; 2(2): 154-60[PubMed]
  • 8. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996; 334(15): 952-7[DOI][PubMed]
  • 9. Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975; 68(11): 1359-65[PubMed]
  • 10. Trevisan M, Farinaro E, Krogh V, Jossa F, Giumetti D, Fusco G, et al. Baldness and coronary heart disease risk factors. J Clin Epidemiol. 1993; 46(10): 1213-8[PubMed]
  • 11. Ford ES, Freedman DS, Byers T. Baldness and ischemic heart disease in a national sample of men. Am J Epidemiol. 1996; 143(7): 651-7[PubMed]
  • 12. Lotufo PA, Chae CU, Ajani UA, Hennekens CH, Manson JE. Male pattern baldness and coronary heart disease: the Physicians' Health Study. Arch Intern Med. 2000; 160(2): 165-71[PubMed]
  • 13. Yamada T, Hara K, Umematsu H, Kadowaki T. Male pattern baldness and its association with coronary heart disease: a meta-analysis. BMJ Open. 2013; 3(4)[DOI][PubMed]
  • 14. Arias-Santiago S, Gutierrez-Salmeron MT, Castellote-Caballero L, Buendia-Eisman A, Naranjo-Sintes R. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. J Am Acad Dermatol. 2010; 63(3): 420-9[DOI][PubMed]
  • 15. Ellis JA, Stebbing M, Harrap SB. Male pattern baldness is not associated with established cardiovascular risk factors in the general population. Clin Sci (Lond). 2001; 100(4): 401-4[PubMed]
  • 16. Arias-Santiago S, Gutierrez-Salmeron MT, Buendia-Eisman A, Giron-Prieto MS, Naranjo-Sintes R. A comparative study of dyslipidaemia in men and woman with androgenic alopecia. Acta Derm Venereol. 2010; 90(5): 485-7[DOI][PubMed]
  • 17. Schnohr P, Lange P, Nyboe J, Appleyard M, Jensen G. Gray hair, baldness, and wrinkles in relation to myocardial infarction: the Copenhagen City Heart Study. Am Heart J. 1995; 130(5): 1003-10[PubMed]
  • 18. Pomerantz HZ. The relationship between coronary heart disease and the presence of certain physical characteristics. Can Med Assoc J. 1962; 86: 57-60[PubMed]
  • 19. Gould L, Reddy CV, Oh KC, Kim SG, Becker W. Premature hair graying: a probable coronary risk factor. Angiology. 1978; 29(11): 800-3[PubMed]
  • 20. Eisenstein I, Edelstein J. Gray hair in black males a possible risk factor in coronary artery disease. Angiology. 1982; 33(10): 652-4[PubMed]
  • 21. Van Neste D, Tobin DJ. Hair cycle and hair pigmentation: dynamic interactions and changes associated with aging. Micron. 2004; 35(3): 193-200[DOI][PubMed]
  • 22. Tobin DJ, Paus R. Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol. 2001; 36(1): 29-54[PubMed]
  • 23. Kauser S, Thody AJ, Schallreuter KU, Gummer CL, Tobin DJ. A fully functional proopiomelanocortin/melanocortin-1 receptor system regulates the differentiation of human scalp hair follicle melanocytes. Endocrinology. 2005; 146(2): 532-43[DOI][PubMed]
  • 24. Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004; 84(4): 1155-228[DOI][PubMed]
  • 25. Lindner G, Botchkarev VA, Botchkareva NV, Ling G, van der Veen C, Paus R. Analysis of apoptosis during hair follicle regression (catagen). Am J Pathol. 1997; 151(6): 1601-17[PubMed]
  • 26. Mecklenburg L, Tobin DJ, Muller-Rover S, Handjiski B, Wendt G, Peters EM, et al. Active hair growth (anagen) is associated with angiogenesis. J Invest Dermatol. 2000; 114(5): 909-16[DOI][PubMed]
  • 27. Glasser M. Is early onset of gray hair a risk factor? Med Hypotheses. 1991; 36(4): 404-11[PubMed]
  • 28. Parker F. Xanthomas and hyperlipidemias. J Am Acad Dermatol. 1985; 13(1): 1-30[PubMed]
  • 29. Gagne C, Moorjani S, Brun D, Toussaint M, Lupien PJ. Heterozygous familial hypercholesterolemia. Relationship between plasma lipids, lipoproteins, clinical manifestations and ischaemic heart disease in men and women. Atherosclerosis. 1979; 34(1): 13-24[PubMed]
  • 30. van Aalst-Cohen ES, Jansen AC, Tanck MW, Defesche JC, Trip MD, Lansberg PJ, et al. Diagnosing familial hypercholesterolaemia: the relevance of genetic testing. Eur Heart J. 2006; 27(18): 2240-6[DOI][PubMed]
  • 31. Humphries SE, Cranston T, Allen M, Middleton-Price H, Fernandez MC, Senior V, et al. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing. J Mol Med (Berl). 2006; 84(3): 203-14[DOI][PubMed]
  • 32. Watanabe A, Yoshimura A, Wakasugi T, Tatami R, Ueda K, Ueda R, et al. Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum. Atherosclerosis. 1981; 38(3-4): 283-90[PubMed]
  • 33. Christoffersen M, Frikke-Schmidt R, Schnohr P, Jensen GB, Nordestgaard BG, Tybjaerg-Hansen A. Visible age-related signs and risk of ischemic heart disease in the general population: a prospective cohort study. Circulation. 2014; 129(9): 990-8[DOI][PubMed]
  • 34. Oosterveer DM, Versmissen J, Yazdanpanah M, Hamza TH, Sijbrands EJ. Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis. Atherosclerosis. 2009; 207(2): 311-7[DOI][PubMed]
  • 35. Christoffersen M, Frikke-Schmidt R, Schnohr P, Jensen GB, Nordestgaard BG, Tybjaerg-Hansen A. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. BMJ. 2011; 343[DOI][PubMed]
  • 36. Bergman R. The pathogenesis and clinical significance of xanthelasma palpebrarum. J Am Acad Dermatol. 1994; 30(2 Pt 1): 236-42[PubMed]
  • 37. Civeira F, Castillo S, Alonso R, Merino-Ibarra E, Cenarro A, Artied M, et al. Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation. Arterioscler Thromb Vasc Biol. 2005; 25(9): 1960-5[DOI][PubMed]
  • 38. Friedlander AH, Scully C. Diagonal ear lobe crease and atherosclerosis: a review of the medical literature and oral and maxillofacial implications. J Oral Maxillofac Surg. 2010; 68(12): 3043-50[DOI][PubMed]
  • 39. Lichstein E, Chadda KD, Naik D, Gupta PK. Diagonal ear-lobe crease: prevalence and implications as a coronary risk factor. N Engl J Med. 1974; 290(11): 615-6[DOI][PubMed]
  • 40. Kaukola S. The diagonal ear-lobe crease, a physical sign associated with coronary heart disease. Acta Med Scand Suppl. 1978; 619: 1-49[PubMed]
  • 41. Kaukola S, Manninen V, Valle M, Halonen PI. Ear-lobe crease and coronary atherosclerosis. Lancet. 1979; 2(8156-8157): 1377[PubMed]
  • 42. Shmilovich H, Cheng VY, Rajani R, Dey D, Tamarappoo BK, Nakazato R, et al. Relation of diagonal ear lobe crease to the presence, extent, and severity of coronary artery disease determined by coronary computed tomography angiography. Am J Cardiol. 2012; 109(9): 1283-7[DOI][PubMed]
  • 43. Gutiu I, el Rifai C, Mallozi M. Relation between diagonal ear lobe crease and ischemic chronic heart disease and the factors of coronary risk. Med Interne. 1986; 24(2): 111-6[PubMed]
  • 44. Friedlander AH, Lopez-Lopez J, Velasco-Ortega E. Diagonal ear lobe crease and atherosclerosis: a review of the medical literature and dental implications. Med Oral Patol Oral Cir Bucal. 2012; 17(1)-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments